Private company

ALPINE IMMUNE SCIENCES, INC.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address188 East Blaine St., Suite 200, Seattle, Wa 981022
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-75.2%Operating margin3
-54.7%Net margin3
95.8%Revenue growth, 20233
-9.8%Return on equity3
-$79.5MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Research and development100¢$80.9M
  • Interest0¢$98.0K
  • Income tax0¢$103.0K

Out of $58.9M in revenue.3 The company lost money this year.

Financial statements

Revenue45673$58.9M in 2023+3301% since 2017
0$20.0M$40.0M$60.0M2017: $1.7M$1.7M20172018: $705.0K$705.0K2018−59%2019: $1.7M$1.7M2019+147%2020: $9.3M$9.3M2020+436%2021: $23.4M$23.4M2021+151%2022: $30.1M$30.1M2022+28%2023: $58.9M$58.9M2023+96%
Operating income45673-$44.2M in 2023+196% since 2017
-$60.0M-$40.0M-$20.0M02017: -$15.0M-$15.0M20172018: -$37.8M-$37.8M2018+153%2019: -$43.6M-$43.6M2019+15%2020: -$28.7M-$28.7M2020−34%2021: -$49.9M-$49.9M2021+73%2022: -$58.1M-$58.1M2022+17%2023: -$44.2M-$44.2M2023−24%
Net income45673-$32.2M in 2023+314% since 2017
-$60.0M-$40.0M-$20.0M02017: -$7.8M-$7.8M20172018: -$36.5M-$36.5M2018+369%2019: -$41.9M-$41.9M2019+15%2020: -$27.9M-$27.9M2020−33%2021: -$50.3M-$50.3M2021+80%2022: -$57.8M-$57.8M2022+15%2023: -$32.2M-$32.2M2023−44%
Fiscal year2017201820192020202120222023
Revenue$1.7M4$705.0K5$1.7M6$9.3M7$23.4M3$30.1M3$58.9M3
Research and development$10.6M4$29.0M5$35.8M6$27.2M7$58.7M3$70.2M3$80.9M3
Operating income-$15.0M4-$37.8M5-$43.6M6-$28.7M7-$49.9M3-$58.1M3-$44.2M3
Interest$152.0K4$319.0K5$338.0K6$775.0K7$816.0K3$476.0K3$98.0K3
Income tax-$200.0K4-$366.0K5$06-$6.0K7-$87.0K3$2.3M3$103.0K3
Net income-$7.8M4-$36.5M5-$41.9M6-$27.9M7-$50.3M3-$57.8M3-$32.2M3
Earnings per share-$2.286-$1.347-$1.983-$1.733-$0.643
Earnings per share (diluted)-$2.286-$1.347-$1.983-$1.733-$0.643

Compare ALPINE IMMUNE SCIENCES, INC. with another company

Former names

  • Nivalis Therapeutics, Inc.Feb 13, 2015 to Jul 25, 20172
  • N30 Pharmaceuticals, Inc.Nov 25, 2014 to Nov 25, 20142

Recent filings

  1. May 20, 20248-K
  2. May 20, 20244
  3. May 20, 20244
  4. May 20, 20244
  5. May 20, 20244
  6. May 20, 20244
  7. May 20, 20244
  8. May 20, 20244
  9. May 20, 20244
  10. May 20, 20244
  11. May 20, 20244
  12. May 20, 20244
  13. May 20, 20244
  14. May 20, 20244
  15. May 10, 20244

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11